Catalyst Wire Dossier Catalyst Wire Dossier

CLS-AX CLS1002-101

· Clearside Biomedical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLS-AX CLS1002-101, covering 2024-03-04 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

See pricing